The Inaugural Cancer Precision Medicine Forum 2019 will take place on 2 and 3 December 2019 in Berlin. Germany. The forum brings together experts from across Europe and beyond for meaningful interactions with those at the very forefront of precision oncology. With a strictly limited attendance (max 300) the forum provides the opportunity to network in an intimate setting, allowing free flowing debate and interactions focussed on collaboration.
Professor Lars Bullinger, Professor in Personalized Medicine at Charité and Lead of HARMONY Workpackage 2: Definitions of Outcomes, will present and participate in session three: Advancing Precision Medicine through Partnerships, collaboration & funding initiatives, taking place on day 1 of the Forum.
The effective implementation of precision medicine needs collaborative approaches, both national and cross-border. Identifying and bringing together different stakeholders, and finding appropriate financial mechanisms are key elements; as well as a need to encourage multi-institutional and cross-border collaboration and facilitate transparent and effective data-sharing. This session will explore what can, and is being, achieved, through different European projects.
HARMONY Research Projects address specific questions for blood cancers - Hematologic Malignancies (HM). Relevant outcomes for patients and caregivers are defined for each HM. The HARMONY projects are focusing on those particular outcomes that will expand our knowledge of HMs and therapeutic approaches.
Interested to become involved in the HARMONY Alliance, please contact us >
Receive the latest news. Click here to subscribe!